Literature DB >> 15206905

A novel retinoic acid-response element requires an enhancer element mediator for transcriptional activation.

Laura R Harris1, Olli-Pekka Kamarainen, Minna Sevakivi, Gwen C Miller, James W Clarke, Jennifer L Potter, Laura C Bridgewater.   

Abstract

The Col11a2 gene codes for alpha2(XI), a subunit of type XI collagen that is a critical component of the cartilage extracellular matrix. The 5' regulatory region of Col11a2 was subjected to deletional analysis to detect any regulatory element in addition to the two known chondrocyte-specific enhancer elements B/C and D/E. Deletion of the region from -342 to -242 bp reduced transcriptional activity to less than 50% of wild-type, but the sequence showed no independent ability to increase transcription from a minimal promoter. When cloned downstream of the D/E enhancer, however, a subsection of the sequence nearly doubled transcriptional activity and produced an additional 3-fold activation in response to RA (retinoic acid). A 6-bp direct repeat, separated by 4 bp (a DR-4 element) near the 5'-end of this region, was found to be essential for its activity, and was further shown to bind the RA X receptor beta in electrophoretic mobility-shift assays. The present study has revealed a novel RA-response element in Col11a2 that does not interact directly with the promoter, but instead requires the D/E enhancer to mediate transcriptional activation. Proteins bound at the enhancer, therefore, would be expected to affect the transcriptional response to RA. Such a system of regulation, particularly if found to be operating in other cartilage genes, could explain the conflicting responses RA produces in chondrocytes under different experimental conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15206905      PMCID: PMC1134041          DOI: 10.1042/BJ20040715

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes.

Authors:  S Annunen; J Körkkö; M Czarny; M L Warman; H G Brunner; H Kääriäinen; J B Mulliken; L Tranebjaerg; D G Brooks; G F Cox; J R Cruysberg; M A Curtis; S L Davenport; C A Friedrich; I Kaitila; M R Krawczynski; A Latos-Bielenska; S Mukai; B R Olsen; N Shinno; M Somer; M Vikkula; J Zlotogora; D J Prockop; L Ala-Kokko
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

2.  Identification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2(XI) collagen gene.

Authors:  Y Liu; H Li; K Tanaka; N Tsumaki; Y Yamada
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

Review 3.  Nuclear hormone receptors and gene expression.

Authors:  A Aranda; A Pascual
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

4.  Adjacent DNA sequences modulate Sox9 transcriptional activation at paired Sox sites in three chondrocyte-specific enhancer elements.

Authors:  Laura C Bridgewater; Marlan D Walker; Gwen C Miller; Trevor A Ellison; L Daniel Holsinger; Jennifer L Potter; Todd L Jackson; Reuben K Chen; Vicki L Winkel; Zhaoping Zhang; Sandra McKinney; Benoit de Crombrugghe
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

5.  A type XI collagen mutation leads to increased degradation of type II collagen in articular cartilage.

Authors:  R R Rodriguez; R E Seegmiller; M R Stark; L C Bridgewater
Journal:  Osteoarthritis Cartilage       Date:  2004-04       Impact factor: 6.576

6.  GA-binding protein (GABP) and Sp1 are required, along with retinoid receptors, to mediate retinoic acid responsiveness of CD18 (beta 2 leukocyte integrin): a novel mechanism of transcriptional regulation in myeloid cells.

Authors:  Thomas S Bush; Michele St Coeur; Karen K Resendes; Alan G Rosmarin
Journal:  Blood       Date:  2003-01-01       Impact factor: 22.113

7.  Oto- spondylo-megaepiphyseal dysplasia (OSMED): clinical description of three patients homozygous for a missense mutation in the COL11A2 gene.

Authors:  M A van Steensel; P Buma; M C de Waal Malefijt; F H van den Hoogen; H G Brunner
Journal:  Am J Med Genet       Date:  1997-06-13

8.  Transcriptional suppression of Sox9 expression in chondrocytes by retinoic acid.

Authors:  I Sekiya; P Koopman; K Tsuji; S Mertin; V Harley; Y Yamada; K Shinomiya; A Niguji; M Noda
Journal:  J Cell Biochem Suppl       Date:  2001

9.  Structural organization of distinct domains within the non-collagenous N-terminal region of collagen type XI.

Authors:  K E Gregory; J T Oxford; Y Chen; J E Gambee; S P Gygi; R Aebersold; P J Neame; D E Mechling; H P Bächinger; N P Morris
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

10.  A new chondrodystrophic mutant in mice. Electron microscopy of normal and abnormal chondrogenesis.

Authors:  R Seegmiller; F C Fraser; H Sheldon
Journal:  J Cell Biol       Date:  1971-03       Impact factor: 10.539

View more
  1 in total

1.  Enhancing enhancers: new complexities in the retinoid regulation of gene expression.

Authors:  Chris P F Redfern
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.